Teva Pharmaceutical reported 3.91B in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Aspen Pharmacare APN:SJ 18.63B 958M
Cipla CIPLA:IN IR 55043.5M 8979M
Dr.Reddys Laboratories DRRD:IN IR 49451M 1769M
Guangzhou Baiy 600332:CH CH 16082.63M 3963.32M
Jiangsu Hengrui Me. 600276:CH CH 6368.49M 560.57M
Kalbe Farma Tbk Pt KLBF:IJ RI 6355012.12M 339597.57M
Richter Gedeon RICHT:HB 155.91B 15.02B
Sh Fosun Pharma 600196:CH CH 8896.28M 840.16M
Sun Pharmaceuticals SUNP:IN IR 97187.4M 11957.6M
Teva Pharmaceutical TEVA:IT 3.91B 72M